Work

Initial screening efforts for the OPTIC RCC trial.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.4_suppl.478

Authors: Scott Mattox Haake, Katy Beckermann, Yu-Wei Chen, Anupama Reddy, Nataliya Mar, Moshe Chaim Ornstein, Pedro C. Barata, Tian Zhang, Sumanta Kumar Pal, W. Kimryn Rathmell, Brian I. Rini

Institutions: Vanderbilt University Medical Center, Moores Cancer Center, University of California, Irvine, UC Irvine Health, Cleveland Clinic, University Hospitals of Cleveland, University Hospitals Seidman Cancer Center, The University of Texas Southwestern Medical Center, City Of Hope National Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Department of Defense

OpenAlex ID: W4391301903

Cites:

Cited by: 5

Related to: 10